EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:EWL • US28176E1082

69.87 EUR
+1.99 (+2.93%)
Last: Feb 2, 2026, 07:00 PM
Fundamental Rating

7

Overall EWL gets a fundamental rating of 7 out of 10. We evaluated EWL against 68 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, EWL is valued expensive at the moment. This makes EWL very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • EWL had a positive operating cash flow in the past year.
  • EWL had positive earnings in each of the past 5 years.
  • EWL had a positive operating cash flow in each of the past 5 years.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • EWL has a better Return On Assets (10.31%) than 91.18% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.40%, EWL is in the better half of the industry, outperforming 77.94% of the companies in the same industry.
  • EWL's Return On Invested Capital of 9.83% is fine compared to the rest of the industry. EWL outperforms 79.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EWL is above the industry average of 9.62%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • EWL has a Profit Margin of 23.25%. This is amongst the best in the industry. EWL outperforms 94.12% of its industry peers.
  • EWL's Profit Margin has improved in the last couple of years.
  • EWL has a better Operating Margin (27.73%) than 97.06% of its industry peers.
  • EWL's Operating Margin has been stable in the last couple of years.
  • EWL's Gross Margin of 78.19% is amongst the best of the industry. EWL outperforms 92.65% of its industry peers.
  • In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

10

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
  • The number of shares outstanding for EWL has been reduced compared to 1 year ago.
  • EWL has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EWL has been reduced compared to a year ago.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 12.16 indicates that EWL is not in any danger for bankruptcy at the moment.
  • EWL has a better Altman-Z score (12.16) than 94.12% of its industry peers.
  • EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
  • EWL has a Debt to FCF ratio of 0.75. This is amongst the best in the industry. EWL outperforms 92.65% of its industry peers.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of EWL (0.06) is better than 86.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 12.16
ROIC/WACC0.97
WACC10.14%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 4.00 indicates that EWL has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.00, EWL belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
  • EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EWL (3.29) is better than 91.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
  • Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • Looking at the last year, EWL shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
  • Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.40% on average over the next years. This is quite good.
  • Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.47% on average per year.
EPS Next Y1.27%
EPS Next 2Y6.3%
EPS Next 3Y7.79%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

  • EWL is valuated quite expensively with a Price/Earnings ratio of 32.20.
  • Compared to the rest of the industry, the Price/Earnings ratio of EWL is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (28.18), we can say EWL is valued inline with the index average.
  • EWL is valuated quite expensively with a Price/Forward Earnings ratio of 27.95.
  • EWL's Price/Forward Earnings is on the same level as the industry average.
  • EWL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.2
Fwd PE 27.95
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EWL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
Industry RankSector Rank
P/FCF 60.04
EV/EBITDA 24.39
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • EWL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)25.42
PEG (5Y)4.52
EPS Next 2Y6.3%
EPS Next 3Y7.79%

0

5. Dividend

5.1 Amount

  • EWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EDWARDS LIFESCIENCES CORP

FRA:EWL (2/2/2026, 7:00:00 PM)

69.87

+1.99 (+2.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap40.55B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target84.6 (21.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)3.56%
PT rev (3m)10.47%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)0.74%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)2.87%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.91%
Valuation
Industry RankSector Rank
PE 32.2
Fwd PE 27.95
P/S 8.16
P/FCF 60.04
P/OCF 47.21
P/B 4.7
P/tB 6.57
EV/EBITDA 24.39
EPS(TTM)2.17
EY3.11%
EPS(NY)2.5
Fwd EY3.58%
FCF(TTM)1.16
FCFY1.67%
OCF(TTM)1.48
OCFY2.12%
SpS8.56
BVpS14.85
TBVpS10.63
PEG (NY)25.42
PEG (5Y)4.52
Graham Number26.93
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 12.16
F-Score6
WACC10.14%
ROIC/WACC0.97
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.27%
EPS Next 2Y6.3%
EPS Next 3Y7.79%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.2 and the Price/Book (PB) ratio is 4.7.